RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)

简要总结

主要结局

次要结局

• Proportion of patients who undergo invasive or non-invasive short-term clinical management according to different type of acute coronary syndrome (STEMI, NSTE-ACS and Unstable Angina). (Part A)(1st Jan of 2012-1st March of 2015)
• Time from first symptoms onset to the time of hospitalization (Part A)(1st Jan of 2012-1st March of 2015)
• Proportion of patients receiving different types of ACS treatment depending on ACS symptoms duration prior hospitalization. (Part A)(1st Jan of 2012-1st March of 2015)
• Patients demographic and baseline characteristics (age, gender, weight, height). (Part A)(1st Jan of 2012-1st March of 2015)
• Proportion of patients with different type of coronary intervention strategies. (Part A)(1st Jan of 2012-1st March of 2015)
• Proportion of patients who is on ticagrelor treatment during 0-3 months, >3-6 months, >6-9 months, >9-12 months. (Part B)(Up to 2 years)
• Proportion of patients with ticagrelor treatment interruptions according to different clinical and non-clinical events (bleeds, planned and non-planned medical interventions, etc.) during follow-up. (Part B)(Up to 2 years)
• Proportion of patients with thrombo-embolic events during follow-up depending on DAT therapy duration. (Part B)(Up to 2 years)
• Proportion of patients who discontinued ticagrelor and reason to discontinue ticagrelor treatment. (Part B)(Up to 2 years)
• Proportion of patients with significant violations of treatment regimen with ticagrelor. (Part B)(Up to 2 years)
• Start and stop dates of dual antipatelet therapy and ticagrelor (as part of DAT) and duration of exposure to DAT and ticagrelor in real-life setting. (Part B)(Up to 2 years)
• Proportion of patients who discontinued DAT and the reason of discontinuation of DAT in real-life setting. (Part B)(Up to 2 years)
• Proportion of patients who change DAT components and reason to change of DAT. (Part B)(Up to 2 years)
• Proportion of patients with CV-events (recurrent Myocardial Infarction-MI, stroke, ischemia-driven revascularization, death, etc.) in long-term perspective (second year) after index event in real-life setting. (Part B)(Up to 2 years)
• Proportion of patients using different type of antithrombotic therapy in long-term perspective (second year) after index event. (Part B)(Up to 2 years)
• Proportion of patients who managed by cardiologist, therapist and other physician after discharge from the hospital. (Part B)(Up to 2 years)